Differences in PGE2 production between primary human monocytes and differentiated macrophages: Role of IL-1β and TRIF/IRF3

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Endo, Yukinori ^a   Blinova, Ksenia ^a   Romantseva, Tatiana ^a   Golding, Hana ^a   Zaitseva, Marina ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; PROSTAGLANDIN E1; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; BENZYLOXYCARBONYL-VALYL-ALANYL-ASPARTIC ACID; CYCLOOXYGENASE 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; IRF3 PROTEIN, HUMAN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; OLIGOPEPTIDE; PAM(3)CSK(4) PEPTIDE; PTGS2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TICAM1 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; COX 2 GENE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; GENE; HUMAN; HUMAN CELL; MACROPHAGE; MOLECULAR DYNAMICS; MONOCYTE; MOUSE; NONHUMAN; PGE 1 GENE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; AGONISTS; ANIMAL; BIOSYNTHESIS; CELL CULTURE; FEVER; FLOW CYTOMETRY; GENETICS; METABOLISM; MICROBIOLOGY; NONOBESE DIABETIC MOUSE; PHOSPHORYLATION; PHYSIOLOGY; RNA INTERFERENCE; WESTERN BLOTTING;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; FEVER; FLOW CYTOMETRY; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED NOD; MONOCYTES; OLIGOPEPTIDES; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2;

EID: 84901626657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098517     Document Type: Article

References (47)

1. Ivanov AI, Romanovsky AA (2004) Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front Biosci 9: 1977-1993. (Pubitemid 38922897)
2. Jansky L, Vybiral S, Pospisilova D, Roth J, Dornand J, et al. (1995) Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology 62: 55-61.
3. Davidson J, Abul HT, Milton AS, Rotondo D (2001) Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain. Pflugers Arch 442: 526-533. (Pubitemid 32673318)
4. Netea MG, Kullberg BJ, Van Der Meer JW (1999) Do only circulating pyrogenic cytokines act as mediators in the febrile response? A hypothesis. Eur J Clin Invest 29: 351-356. (Pubitemid 29188829)
5. Leon LR (2002) Invited Review: Cytokine regulation of fever: studies using gene knockout mice. Journal of Applied Physiology 92: 2648-2655.
6. Campisi J, Hansen MK, O'Connor KA, Biedenkapp JC, Watkins LR, et al. (2003) Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge. J Appl Physiol 95: 1873-1882. (Pubitemid 37310370)
7. Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, et al. (2005) Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 19: 334-344. (Pubitemid 40797990)
8. Blatteis CM (2007) The onset of fever: new insights into its mechanism. Prog Brain Res 162: 3-14.
9. Steiner AA, Ivanov AI, Serrats J, Hosokawa H, Phayre AN, et al. (2006) Cellular and molecular bases of the initiation of fever. PLoS Biol 4: e284.
10. Derijk RH, Strijbos PJ, van Rooijen N, Rothwell NJ, Berkenbosch F (1993) Fever and thermogenesis in response to bacterial endotoxin involve macrophage-dependent mechanisms in rats. Am J Physiol 265: R1179-1183.
11. Sehic E, Li S, Ungar AL, Blatteis CM (1998) Complement reduction impairs the febrile response of guinea pigs to endotoxin. Am J Physiol 274: R1594-1603.
12. Perlik V, Li Z, Goorha S, Ballou LR, Blatteis CM (2005) LPS-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells. Am J Physiol Regul Integr Comp Physiol 289: R332-R339. (Pubitemid 41060484)
13. Bezugla Y, Kolada A, Kamionka S, Bernard B, Scheibe R, et al. (2006) COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages. Prostaglandins Other Lipid Mediat 79: 93-100.
14. Zaitseva M, Romantseva T, Blinova K, Beren J, Sirota L, et al. (2012) Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo. Vaccine 30: 4859-4865.
15. Hubschle T, Mutze J, Muhlradt PF, Korte S, Gerstberger R, et al. (2006) Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1. Am J Physiol Regul Integr Comp Physiol 290: R180-187.
16. Kozak W, Wrotek S, Kozak A (2006) Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-kappaB. Am J Physiol Regul Integr Comp Physiol 290: R871-880.
17. Greis A, Murgott J, Rafalzik S, Gerstberger R, Hubschle T, et al. (2007) Characterization of the febrile response induced by fibroblast-stimulating lipopeptide-1 in guinea pigs. Am J Physiol Regul Integr Comp Physiol 293: R152-161. (Pubitemid 47092172)
18. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
19. Schreiber E, Matthias P, Muller MM, Schaffner W (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419. (Pubitemid 19198635)
20. Tapping RI, Orr SL, Lawson EM, Soldau K, Tobias PS (1999) Membrane-Anchored Forms of Lipopolysaccharide (LPS)-Binding Protein Do Not Mediate Cellular Responses to LPS Independently of CD14. The Journal of Immunology 162: 5483-5489. (Pubitemid 29307159)
21. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, et al. (2003) LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198: 1043-1055. (Pubitemid 37248620)
22. Lien E, Chow JC, Hawkins LD, McGuinness PD, Miyake K, et al. (2001) A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. J Biol Chem 276: 1873-1880. (Pubitemid 32111740)
23. Murakami M, Kudo I (2004) Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Prog Lipid Res 43: 3-35. (Pubitemid 37433865)
24. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL (2007) Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46: 108-125. (Pubitemid 46661865)
25. Navarro L, David M (1999) p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J Biol Chem 274: 35535-35538. (Pubitemid 129512848)
26. Kagan JC, Su T, Horng T, Chow A, Akira S, et al. (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9: 361-368. (Pubitemid 351405105)
27. Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23: 344-346. (Pubitemid 41443435)
28. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, et al. (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324-2335.
29. Carta S, Tassi S, Pettinati I, Delfino L, Dinarello CA, et al. (2011) The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering. J Biol Chem 286: 27069-27080.
30. Kuroda E, Ishii KJ, Uematsu S, Ohata K, Coban C, et al. (2011) Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms. Immunity 34: 514-526.
31. Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, et al. (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J 26: 2951-2962.
32. Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, et al. (2004) Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci U S A 101: 8815-8820. (Pubitemid 38745854)
33. Gatti S, Beck J, Fantuzzi G, Bartfai T, Dinarello CA (2002) Effect of interleukin-18 on mouse core body temperature. Am J Physiol Regul Integr Comp Physiol 282: R702-709. (Pubitemid 34665643)
34. Raz A, Wyche A, Siegel N, Needleman P (1988) Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem 263: 3022-3028. (Pubitemid 18062959)
35. Shimpo H, Sakai T, Kondo S, Mishima S, Yoda M, et al. (2009) Regulation of prostaglandin E(2) synthesis in cells derived from chondrocytes of patients with osteoarthritis. J Orthop Sci 14: 611-617.
36. Chi P-L, Luo S-F, Hsieh H-L, Lee IT, Hsiao L-D, et al. (2011) Cytosolic phospholipase A2 induction and prostaglandin E2 release by interleukin-1β via the myeloid differentiation factor 88-dependent pathway and cooperation of p300, Akt, and NF-κB activity in human rheumatoid arthritis synovial fibroblasts. Arthritis & Rheumatism 63: 2905-2917.
37. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, et al. (2004) ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5: 373-379. (Pubitemid 38500085)
38. Dinarello CA (1997) Interleukin-1. Cytokine Growth Factor Rev 8: 253-265.
39. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, et al. (2011) CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147: 868-880.
40. Sakaguchi S, Negishi H, Asagiri M, Nakajima C, Mizutani T, et al. (2003) Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 306: 860-866. (Pubitemid 36776210)
41. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658. (Pubitemid 44298214)
42. Janssen E, Ozcan E, Liadaki K, Jabara HH, Manis J, et al. (2014) TRIF Signaling Is Essential for TLR4-Driven IgE Class Switching. J Immunol 192: 2651-2658.
43. Chen J, Zhao M, Rao R, Inoue H, Hao CM (2005) C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. J Biol Chem 280: 16354-16359. (Pubitemid 40616764)
44. Dinarello CA (2004) Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10: 201-222.
45. Long NC, Otterness I, Kunkel SL, Vander AJ, Kluger MJ (1990) Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol 259: R724-728. (Pubitemid 20352343)
46. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, et al. (1996) Effect of endotoxin in IL-1 beta-deficient mice. J Immunol 157: 291-296. (Pubitemid 26190560)
47. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann KJ, et al. (1995) Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity 3: 9-19.